UBS Group AG - TETRAPHASE PHARMACEUTICALS I ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2020$7,000
+75.0%
2,9250.0%0.00%
Q1 2020$4,000
-50.0%
2,925
+0.9%
0.00%
Q4 2019$8,000
-42.9%
2,900
+13.1%
0.00%
Q3 2019$14,0002,5640.00%
Other shareholders

There were no reported owners of TETRAPHASE PHARMACEUTICALS I in Q3 2020.

NameSharesValueWeighting ↓
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders